TELEFLEX INC (TFX) — SEC Financial Statements & Analysis

TELEFLEX INC (TFX) is a surgical & medical instruments & apparatus company, incorporated in DE. TELEFLEX INC trades on NYSE as: TFX. TELEFLEX INC (TFX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, TELEFLEX INC carries a market cap of $5.51B, a P/E ratio of -5.34x, a P/B ratio of 1.90x, a P/S ratio of 2.44x, an enterprise value of $8.00B, and an EV/EBITDA multiple of 71.87x. On profitability, it posts a gross margin of 54.94%, an operating margin of 1.97%, a net margin of -45.76%, a Return on Equity (ROE) of -28.87%, a Return on Assets (ROA) of -14.57%, and a Return on Invested Capital (ROIC) of 0.31%. Per share, it reports EPS of $-23.68, diluted EPS of $-23.63, free cash flow per share of $3.87, and a dividend per share of $1.37. Over the trailing year, it posted revenue growth of 110.94% year-over-year, net income growth of -637.53% year-over-year, and EPS growth of -646.25% year-over-year. On the balance sheet, it maintains a current ratio of 2.60x, a quick ratio of 1.91x, working capital of $1.16B, a debt-to-equity ratio of 1.34x, a debt ratio of 0.57, an interest coverage ratio of 0.39x, free cash flow of $168.40M (TTM), and net debt of $2.49B. Figures sourced from SEC EDGAR.

Market Cap

$5.51B

P/E TTM

-5.34x

EPS TTM

$-23.68

P/B TTM

1.90x

ROE TTM

-28.87%

ROA TTM

-14.57%

Debt To Equity

1.34x

Free Cash Flow TTM

$168.40M

Net Revenue TTM Growth 1Y

110.94%

Data as of 2026-06-30 · Source: SEC EDGAR